06 Jun 2023
26m
How Boston Scientific's acquisition of Obsidio is shaping its interventional oncology business
DeviceTalks Podcast Network
Open in Podwise to generate AI notes
Sign in to process this episode and unlock summaries, transcripts, highlights and translations.
Shownotes are not generated by Podwise.

